[HTML][HTML] Global pandemics interconnected—obesity, impaired metabolic health and COVID-19
Obesity and impaired metabolic health are established risk factors for the non-
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …
communicable diseases (NCDs) type 2 diabetes mellitus, cardiovascular disease …
COVID-19 and liver disease: mechanistic and clinical perspectives
Our understanding of the hepatic consequences of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
coronavirus 2 (SARS-CoV-2) infection and its resultant coronavirus disease 2019 (COVID …
[HTML][HTML] Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
Background & Aims Chronic liver disease (CLD) and cirrhosis are associated with immune
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
[HTML][HTML] Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and
ESCMID published a position paper to provide guidance for physicians involved in the care …
ESCMID published a position paper to provide guidance for physicians involved in the care …
Diabetes mellitus, energy metabolism, and COVID-19
C Conte, E Cipponeri, M Roden - Endocrine Reviews, 2024 - academic.oup.com
Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …
[PDF][PDF] Impact of COVID‐19 in liver disease progression
MA Martinez, S Franco - Hepatology Communications, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) is a novel coronavirus
that causes coronavirus disease 19 (COVID‐19), which has infected millions of people …
that causes coronavirus disease 19 (COVID‐19), which has infected millions of people …
Infections at the nexus of metabolic-associated fatty liver disease
J Boeckmans, M Rombaut, T Demuyser… - Archives of …, 2021 - Springer
Metabolic-associated fatty liver disease (MAFLD) is a chronic liver disease that affects about
a quarter of the world population. MAFLD encompasses different disease stadia ranging …
a quarter of the world population. MAFLD encompasses different disease stadia ranging …
Infection of liver hepatocytes with SARS-CoV-2
E Barnes - Nature Metabolism, 2022 - nature.com
Multi-organ disease in patients seriously unwell with COVID-19 is commonly reported.
However, debate exists as to whether extra-pulmonary manifestations are the result of …
However, debate exists as to whether extra-pulmonary manifestations are the result of …
[HTML][HTML] COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
become an ongoing global health pandemic. Since 2019, the pandemic continues to cast a …
become an ongoing global health pandemic. Since 2019, the pandemic continues to cast a …